Osaic Holdings’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.1M Buy
328,111
+70,299
+27% +$5.38M 0.06% 341
2025
Q1
$17.9M Buy
257,812
+17,148
+7% +$1.19M 0.04% 450
2024
Q4
$20.7M Sell
240,664
-65,914
-21% -$5.67M 0.05% 389
2024
Q3
$36.5M Sell
306,578
-69,340
-18% -$8.26M 0.08% 241
2024
Q2
$53.7M Buy
375,918
+12,080
+3% +$1.73M 0.13% 158
2024
Q1
$46.7M Sell
363,838
-174,270
-32% -$22.4M 0.1% 193
2023
Q4
$55.7M Sell
538,108
-106,767
-17% -$11M 0.1% 195
2023
Q3
$58.7M Buy
644,875
+226,013
+54% +$20.6M 0.09% 211
2023
Q2
$33.8M Buy
418,862
+42,842
+11% +$3.46M 0.06% 287
2023
Q1
$29.9M Buy
376,020
+33,364
+10% +$2.66M 0.06% 319
2022
Q4
$23.2M Buy
342,656
+2,552
+0.8% +$173K 0.05% 387
2022
Q3
$16.9M Buy
340,104
+7,618
+2% +$380K 0.04% 438
2022
Q2
$18.5M Buy
332,486
+86,146
+35% +$4.8M 0.04% 409
2022
Q1
$12.3M Buy
246,340
+48,218
+24% +$2.41M 0.02% 647
2021
Q4
$11.1M Buy
198,122
+19,988
+11% +$1.12M 0.02% 689
2021
Q3
$8.55M Buy
178,134
+11,476
+7% +$551K 0.02% 743
2021
Q2
$6.99M Buy
166,658
+16,918
+11% +$710K 0.02% 842
2021
Q1
$5.05M Buy
149,740
+4,954
+3% +$167K 0.01% 963
2020
Q4
$5.06M Sell
144,786
-344
-0.2% -$12K 0.01% 861
2020
Q3
$5M Sell
145,130
-13,488
-9% -$465K 0.02% 757
2020
Q2
$5.19M Sell
158,618
-37,846
-19% -$1.24M 0.02% 676
2020
Q1
$4.79M Buy
+196,464
New +$4.79M 0.02% 628